Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ12850,55
KB-0,26
PKN94,8494,871,30
Msft474,56474,6-0,84
Nokia5,15,3980,42
IBM309,08309,350,04
Mercedes-Benz Group AG61,161,12-1,20
PFE26,3626,371,99
15.12.2025 18:35:58
Indexy online
AD Index online
select
AD Index online
 

  • 15.12.2025 18:00:00
Asker Health Grp Rg (Stockholm)
Poslední obchod Změna (%) Změna (SEK) Objem obchodů (SEK)
88,20 2,23 1,92 21 868 612
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.12.2025
Popis společnosti
Obecné informace
Název společnostiAsker Healthcare Group AB
TickerASKER
Kmenové akcie:Ordinary Shares
RICASKER.ST
ISINSE0024171458
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.06.2025
Počet zaměstnanců k 30.06.2025 4 266
Akcie v oběhu k 30.06.2025 383 036 497
MěnaSEK
Kontaktní informace
UliceSvardvagen 3A
MěstoDANDERYD
PSČ182 33
ZeměSweden
Kontatní osobaThomas Moss
Funkce kontaktní osobyChief Financial Officer, Head - Investor Relations
Telefon46 855 601 100

Business Summary: Asker Healthcare Group AB is a Sweden-based primarily engaged in the healthcare industry. The Company focuses on providing medical products and solutions to caregivers and patients across Europe. Vision of Asker Healthcare Group AB is to be the healthcare group in Europe within medical products and solutions, by building and acquiring companies that together with healthcare providers and patients create better health for all. To achieve this vision, the Company has adopted a twin engine growth strategy that combines organic and acquired growth. Asker Healthcare Group AB continuously acquires small and medium-sized companies that complement its existing business. The companies acquired brings a wider product range, new geographies, customer segments or channels to the Group.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Asker Healthcare Group AB revenues increased 12% to SEK7.98B. Net income applicable to common stockholders increased 24% to SEK220M. Revenues reflect West segment increase of 79% to SEK4.03B. Net income benefited from Financial income increase from SEK59M to SEK159M (income), Other operating expenses decrease of 19% to SEK66M (expense).
Odvětvová klasifikace
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
SICSurgical And Medical Instruments
SICElectromedical Equipment



  • Poslední aktualizace: 15.12.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive OfficerJohan Falk54
Chief Financial Officer, Head - Investor RelationsThomas Moss52
Chief Operating OfficerPeter Gustafsson53
General CounselJennie Espelund41
Head - IT IntegrityMattias Jaran53
Head - Human ResourcesKerstin Mjoemark46
Head - Mergers & AcquisitionsOla Nordh48
Head - ESGSanna Norman49
Head - CommunicationEmma Rheborg53